Description
Composition Daunorubicin Hydrochloride for Injection IP 20 mg, Powder for Injection
Shipping class Cold
Primary Use Blood cancer
cautionPotentially unsafe with Lactation
Medicine Overview of Daunomycin Injection
Uses of Daunomycin Injection
Daunomycin 20mg Injection is used in the treatment of blood cancer.
Daunomycin Injection side effects
Common
Nausea, Vomiting, Low blood platelets, Ulcer, Infection, Abdominal pain, Loss of appetite, Decreased white blood cell count, Hair loss, Fever, Decreased blood cells (red cells, white cells, and platelets), Fatigue, Anemia (low number of red blood cells), Chills, Diarrhoea, Mucosal inflammation, Febrile neutropenia, Stomatitis (Inflammation of the mouth), Breathing difficulty.
How to use Daunomycin Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Daunomycin Injection works
Daunomycin 20mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
In Depth Information on Daunomycin Injection
Expert advice for Daunomycin Injection
- You must undergo careful examination of functioning of the heart as daunorubicin is known to cause life-threatening heart problems due to damage to heart muscles (myocardium).
- Daunorubicin should be used cautiously is elderly, children, and patients with high blood pressure (manifest arterial hypertension) due to increased risk of developing heart complications.
- You may be frequently examined for complete blood-count (blood cells, proteins, hemoglobin), kidney, liver and heart function before and during the course of treatment.
- Tell your doctor if you have had, have an ongoing or scheduled radiation therapy or X-ray of the chest area. Daunorubicin increases the risk of reactions at the site of radiation therapy (or risk of heart problem if the chest area is involved) and should be used cautiously.
- You should be monitored for worsening of infections and development of life-threatening infections (e.g. viral infections like herpes zoster) as daunorubicin is known to suppress the activity of the immune system.
- Liposomal preparation of daunorubicin is not recommended for use in children <18 years.
- Before starting daunorubicin treatment, make sure that you are free from any side effects of previous chemotherapy (inflammation of the mouth, abnormal blood cell counts and generalized infections).
- Both partners should take extreme care to avoid pregnancy while on daunorubicin therapy and consult your doctor if you get to know that you are pregnant.
Daunomycin Injection related warnings
Special precautions for Daunomycin Injection
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
WEIGH RISKS VS BENEFITS
Daunomycin 20mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Lactation
UNSAFE
Daunomycin 20mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Driving
Daunomycin 20mg Injection may cause side effects which could affect your ability to drive.
Kidney
CAUTION
Daunomycin 20mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Daunomycin 20mg Injection may be needed. Please consult your doctor. Use of Daunomycin 20mg Injection is not recommended in patients with severe kidney disease.
Liver
CAUTION
Daunomycin 20mg Injection should be used with caution in patients with liver disease. Dose adjustment of Daunomycin 20mg Injection may be needed. Please consult your doctor. Use of Daunomycin 20mg Injection is not recommended in patients with severe liver disease.
